Guideline interval: A new time interval in the diagnostic pathway for symptomatic cancer

Abstract

Highlights We describe a new metric to describe the cancer diagnostic pathway: guideline interval. Guideline interval increases less with multimorbidity compared with diagnostic interval. We illustrate guideline interval using UK NICE suspected-cancer referral guidance. Guideline interval is readily modifiable to local policies or updates. Guideline interval is readily adaptable to local suspected-cancer policies.